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Can Social Contagion Help Global Health ‘Jump the Shark’?
Comment on “How to Facilitate Social Contagion?”
Introduction
In the third of a series of articles on the possibilities for (social) 
network theory and analysis in health systems policy and 
management, Karl Blanchet gives a good introduction to ‘How 
to facilitate social contagion?’ (1–3). That is, how to use social 
networks to spread ‘innovations’ or ideas in (international) 
public health. Interestingly, while the article focuses on ‘how’, 
answers to the questions of: ‘What idea(s) or ‘innovations’ are 
being considered for viral spread?’, or; ‘Why?’; seem so self-
evident as to receive little, or only tangential consideration. But 
without answering these questions, it would seem unlikely that 
recent ideas and innovations about international public health 
will ‘Jump the Shark’ (4). 
The conclusion must surely be that while (social and 
commercial) marketing and advocacy in medicine and public/
global health will continue to attempt to use social networks 
instrumentally as a tactical tool to ‘sell’ or ‘virally market’ 
products and policies; social network analyses and network 
theory may be of far greater value for strategic analyses. Adaptive 
health policy strategies might then be formulated that while not 
focused on occasional great leaps in public health and well-
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Abstract
The instrumental use of social networks has become a central tenet 
of international health policy and advocacy since the Millennium 
project. In asking, ‘How to facilitate social contagion?’, Karl Blanchet 
of the London School of Hygiene and Tropical Medicine therefore 
reflects not only on the recent success, but also hints to growing 
challenges; the tactics of partnerships, alliances and platforms no 
longer seem to be delivering at the same rate and maybe reversing. 
A better understanding of how social networks work may therefore 
be needed to strengthen a tactical instrument that has been used to 
remarkable recent effect. But in focusing on the unbounded rhetoric 
and narrative options of Global Health, the danger will surely be 
on missing the fundamental factors constraining network growth. 
Future growth will depend on understanding these constraints, 
and Global Health may do well to think of social networks not only 
instrumentally, but also analytically in terms of the strategic contexts 
and environments in which such instruments are deployed. 
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being, could lead to something as if not more valuable in the 
longer-term; continuous tiny improvements.
Viral social marketing and jumping the shark
Interest in social contagion and the spread of innovations 
and ideas through medical and health networks is not new. 
The classic study by Coleman, Katz and Menzel related to the 
diffusion of Tetracycline amongst physicians in four cities of 
the US Midwest in the 1950’s (5). Diffusion theory and the 
spread of ideas and innovations through social structures and 
networks can arguably be traced back to the French sociologist 
Tarde in the 19th century. What is perhaps newer, has been the 
idea since the Millennium Development Goals (MDSs) that not 
only intangible (health and social) policy goal(s) and even the 
‘values’ can be marketed and spread in the same way as tangible 
technologies, but also the active diffusion of these ideas might be 
possible at a global level and across a vast array of cultures and 
languages (6). By creating ‘partnerships’ between high-influence 
‘nodes’ across (sub-) networks—even networks superficially 
at odds with one another such as western humanitarian 
organisations  and international pharmaceutical companies—it 
is possible to advance and even accelerate the adoption of any 
policy idea or ‘innovation’.
The power of using social networks instrumentally in this 
way for international public health is now seldom disputed. 
Indeed, though Country Coordination Mechanisms (CCMs) 
under the Global Fund, national and (inter-) national health 
(sector) advocacy networks were expanded and to some extent 
formalized. Global development assistance for health has also 
increased from approximately US$10 Billion in 2000 to US$28 
Billion by 2010 (2010 prices) (7). But the title of the report from 
which these data are taken also anticipates what many now fear; 
‘The End of a Golden Era’. Since 2010, international funding for 
health has levelled out and may even be declining, and drug 
resistance and pathogens continue to adapt. Aggregate data 
for such adverse developments are not yet widely available or 
published, but local effects are already being felt (8). 
It is then hardly surprising that faced with the prospect of failing 
to ‘jump the shark’ after what has been a remarkable advocacy 
(social ‘marketing’) campaign, and avoiding inevitable declines 
at the end of the ‘product life cycle’ of the MDGs and global 
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health innovation that public health professionals, and related 
international agencies, are asking themselves the same question 
as Karl; ‘if evidence of cost-effectiveness is no longer working, 
what evidence might?’ Does a potentially “global health system” 
and movement even run the risk of being stillborn? (9). 
For a solution, Karl suggests looking to the source of success. 
He provides a good introduction. And he also identifies three 
outstanding questions: the characteristics of network links; the 
‘bounds’ to network growth, and; the performance characteristics 
of alternative network architectures. However, only by taking an 
analytical, rather than an instrumental view of social networks 
might it be possible to answer these questions.
Social networks as the context not instruments of health 
policy and management
In the first paper in this series, I suggested that by the simple 
extension of adding economic-, to dominant: sociological-, 
(social) (psychiatric and) psychological-,  and political science-, 
theories and approaches in the field of social network analyses, 
it is possible to distinguish quite clearly between two distinct 
categories of (or “bounds” to and sources of “homophily” within) 
social networks in health systems: networks of those demanding 
and applying physical and real resources to supply health and 
well-being solutions (health professionals), and; networks of 
those supplying the means (in the form of transferable real 
resources) to mobilize those physical resources, but who 
subsequently also enjoy the benefits (real and perceived) of 
health and well-being solutions being offered (insureds). Nor 
are the two networks discrete from one another as individuals 
and organisations (cells and nodes) may belong to both network 
categories simultaneously within, for example, any sovereign 
state (Figure 1) (1).
With respect to the case under discussion, the MDGs and 
Global Health, both the rapid diffusion of ideas and/or expansion 
of networks carrying them, but also subsequent limitations to 
providing ‘cost-effectiveness’, or indeed any other ‘evidence’ or 
narrative and potential reversals of fortune could then easily 
be explained and might even be anticipated. Furthermore, the 
spread of any such idea could also be measured, as for example 
in n-grams, in the lexicological units that articulate the idea or 
innovation—for example, “Tetracycline” or “Global Health” as a 
proper noun. 
Any difficulties will arise not due to the system ‘complexity’ but 
due to the fact that primary variables subject to adaption will 
not be the  real resources contested between the two categories 
of networks (or risk or uncertainty as to future values), but the 
words and discourses used to describe real resource transaction 
and interactions between them! Discussion is unlike to involve 
‘complexity’, cyclical dynamics, as much as complication or 
simply confusion; particularly where, as a result of the so-called 
‘nudging’ and social influencing exercises, such as ‘framing’ or 
‘priming’, lexicological values might change. The use of the term, 
“cost-effectiveness”, is a perfect example.
In contrast to the use of ‘cost-effectiveness’ information and 
evidence in the formulation and marketing of the MDGs and 
international health, the original objective of cost-effectiveness 
research was not to provide ‘evidence’ to ‘mobilize resources’ 
for ‘essential health services’ (positive list formation), it was 
precisely the opposite; rationing (10). Furthermore, the tools 
were not designed for use in development aid and foreign policy 
(discretionary budgets and public) finance, particularly where 
capacity for data and analytical due diligence is limited if not 
absent, but for use in the mandatory public finance budgets 
of legally bound sovereign solidarity networks. The original 
purpose of such information was then to de-prioritize (‘ration’), 
as transparently as possible, less essential services, to ensure 
the survival of sovereign health solidarity systems as a whole 
within the constraints of the fiscal spaces of sovereign solidarity 
networks (11). That is, to establish points of compromise 
between national networks of both funders/users/tax payers and 
suppliers of health services and hence attempt to balance (future 
hence uncertain) real resource imbalances or “risk”. 
Nor can it be a coincidence that cost-effectiveness tools 
were first developed in those two OECD countries where no 
institutional distinction was made, hence negotiating space 
available, between the networks of those supplying and the 
networks demanding, real resources to furnish health and 
well-being solutions in favor of ‘integrated health system’ or 
single hyper-agent representing all networks simultaneously. 
Ironically perhaps, it is also this hierarchical network governance 
architecture that likely facilitated the rapid diffusion of the 
‘innovation’ of using ‘cost-effectiveness’ analysis and evidence 
for such a purpose after William’s seminal paper in 1986 (12). 
Again, this can be tested.
The problem for the MDGs or indeed any subsequent targets 
in Global Health (and well-being) is therefore unlikely to be the 
lack of any particular form of evidence or narrative, or the ability 
to spread that evidence through and across international public 
health networks and related goods and services professional 
(interest) networks, but rather the reliance on “discretionary” 
sovereign public budgets and therefore sovereign (sub-
international) real resource solidarity networks. 
 -
 50.0
 100.0
 150.0
 200.0
 250.0
0 20 40 60 80 10
0
12
0
14
0
16
0
18
0
20
0
22
0
24
0
26
0
28
0
30
0
32
0
34
0
36
0
38
0
40
0
42
0
44
0
46
0
48
0
50
0
52
0
54
0
56
0
58
0
60
0
Networked
Population
units
Time units
Illustrating oscillations in networked populations under a Lotka-Volterra network- based 
model of health systems
Insureds
Health Prof.s
Figure 1. The ‘shark fins’ or cycles of social network expansion and decay under a Lotka-Volterra network-based 
model of health systems
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In social network terms, networks of ‘homophilic’ global 
health and well-being solution suppliers relied on transferable 
real resources (‘finance’) from a clearly identifiable sub-set of 
resource solidarity networks for health and well-being (legally 
bound (‘strong tie’) ‘donor nations’) based purely on the ‘weak 
ties’ of temporary (programmatic) goodwill to enable them 
to manage those real resources within third party solidarity 
networks (‘recipient nations’). The risks (both in iatrogenic and 
financial terms) of this for both ‘donors’ and ‘recipients’ were 
clear from the start and yet tools and narratives to deal with such 
risks, and anticipate the shark, were largely neglected or ignored 
(13).
Physician, health thyself
Unsurprisingly perhaps, given their expertise in virology, 
international public health networks have been some of the 
most successful practitioners in the instrumental use of social 
networks  over the last 15 (if not 150) years. Unlikely alliances 
and national and global “partnerships” encompassing everything 
from Big Pharma executives to grass roots humanitarian and 
religious activists now all strive toward the same goals, citing the 
same evidence and narratives. More evidence and understanding 
of how to foster social contagion may then help further “to build 
on success”. But if that success is not forth-coming, or indeed 
if reversals of fortune become apparent, how might that be 
explained? 
The use of ‘cost-effectiveness’ as one of a number of 
narrative devices amongst (previously largely) self-organizing 
international public health related networks for (global) ‘resource 
mobilization’ through the MDGs—rather than a decision rule 
for resource rationing and risk management in sovereign health 
system and public finance contexts—therefore provides one 
of a number of means to track an epic experiment in Social 
Network Analysis (SNA), social contagion, and the diffusion of 
an ‘innovation’ in (public) health policy. The experiment also 
has a clear and approaching end date. But what is different in 
the 21st century with respect to such analysis however, is not as 
Karl suggests that human networks are new, on the contrary; 
nor that there will not be those who attempt to use social 
networks instrumentally, a foundation of political activity at 
any scale; but it is possible to trace and map network contacts 
and movements—‘social contagion’ and ‘social influencing’—
electronically, at increasingly larger scale, more rapidly, and 
across increasing numbers of possible ties and links (14).
The hypothesis of a network-based theory of health systems 
is therefore a challenge to those international public health 
institutions and networks with the resources to perform such 
(computed) social network analyses to indeed do so; but first 
to test it on themselves, or better allow testing, and their own 
much-vaunted social contagion activities.
The results of any such future (almost certainly novel and trans-
disciplinary) research are hard to predict, but network theory, 
and empirical results in SNA to date, suggest that innovations 
spread quickly through more simple and homophilic networks 
(15). The hierarchical networks of public integrated systems are 
therefore likely to be preferred by those who wish to use social 
networks instrumentally to ‘sell’ or ‘advocate’ products and 
policies. However, hierarchical networks are also characterized 
by higher degrees of network density and centrality; and 
therefore also linked, as Karl indeed indicates, to selectivity and 
also blocking (other) innovations. 
But this is a challenge that global health networks cannot really 
afford to ignore; because the risks relate not only to ‘resource 
mobilization’ (public finance) crises, but also to being able to 
explain public health crises of past and future (16). Establishing 
links between actual health outcomes and the rise and fall of 
legally bound resource solidarity networks, and the exclusive 
health (services) supplier networks these fund, is then a second 
and more complex step; particularly given the relatively modest 
contribution of professional health services to aggregate the 
health status at population levels over the long term (17). Any 
link is likely to be only further complicated where, as for example 
in parts of the former Soviet Union and Yugoslavia, the collapse 
of resource solidarity networks is accompanied by significant 
social dislocation and in some cases extreme communitarian 
violence. 
The  limitations to SNA in international health therefore 
seem largely self-imposed, because the real question of paper, 
and proposals to address it, remains unanswered; Not, ‘How to 
facilitate social contagion?’ but, ‘What are the limits?’.
Finally, the hypothesis suggested to answer this question and 
subsequently commentated but not addressed also suggests 
a line of enquiry towards Karl’s final question and network 
“performance”. Hierarchical homophilic networks will be 
‘powerful’ instruments of social contagion, but two types 
of ideas and innovations are likely to prove more ‘resilient’; 
innovations and ideas for improving health and well-being that 
require few or no real resources, and; innovations and ideas that 
can help those involved in health and well-being activities that 
do require intensive amounts of real resources to identify and 
deal with ‘risk’—or the inevitable possibility given imperfect 
foresight, that any future outcomes may exceed or disappoint 
against current expectations. The first involves removing the 
factor that creates the sharks, the second involves accepting the 
inevitability of sharks, and focusing on attempts to anticipate 
(however uncertainly) their future movements and prepare 
counter-measures.
Conclusion: to jump sharks do not just think; believe.
The fewer real resources cells and nodes of a network needs 
to survive, and the more self-organizing these become, the 
more resilient the networks they constitute and ideas they can 
diffuse. In a world of increasingly high-tech capital intensive 
health and well-being activities, examples of innovations (and 
networks) that require few or no (community) real resources to 
promote human health, seem almost an anathema. But they are 
more common and more culturally diverse and adaptive, than 
might at first be assumed; their age evidence of their continued 
effectiveness and relevance. (Social Enterprise) Networks 
of those supporting the ‘co-production’ of health through, 
particularly immaterial, rituals of individual and group healthy 
lifestyles and behaviours would therefore seem to provide a 
clear alternative (complementary) strategy to improving public 
health and well-being at large scale over long time periods (18, 
19). No occasional giant leaps in public health and well-being 
perhaps, but billions of tiny daily contributions will also add up 
substantially.
With respect to ideas and innovations to anticipate and 
manage return/risk variances, examples are more difficult to 
identify. Particularly in (international) public health, where a 
very constrained set of tools and ideas in economics and finance 
typically stem from the persistent use of WHO definitions of 
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(health) ‘finance’ as simply ‘resource mobilization’ (20). Given 
finance and economics are those applied and theoretical fields 
most centrally concerned with (individual, organisational 
and societal) real resource use and decision-making under 
uncertainty, this constraint is likely to be a significant brake 
on innovative ideas for identifying and dealing with that 
(future) ‘risk’ of variance against expectations. There will be 
no plans ‘B’ and no hedges, only either irrational exuberance 
or denial and anger after the fact. Abuse targeted at the tactical 
risk management tools and narratives in (public) finance and 
economics in public health might therefore be misplaced if not 
misguided, and reflective of failures prepare for the probability 
of sharks springing out of seemingly calm seas (21).
In a world, were the only certain future outcomes are death 
and taxes, the challenge and opportunities of SNA would seem 
to lie therefore; not so much in the further refinement of well-
used tactical instruments in international public health; but 
in starting to understand the strategic contexts in which such 
tactics are employed. Much will depend on the time scale 
of events observed for analysis, and the lessons taken from 
reversals of fortune (22). Ultimately, however, in the long-
term, pluralized and distributed health and well-being system 
networks and architectures would seem to offer a credible and 
proven alternative to ‘integrated’ approaches to health system 
governance. An alternative that might be preferred not only 
by cold-blooded economists, epidemiologists and information 
scientists focusing on managing dangerously accumulating ‘too 
big to fail’ community risk; but also by passionate, culturally 
and linguistically diverse aesthetes who join together in local 
self-organizing networks to perform simple daily rituals and 
activities to promote their own and direct community physical 
and mental health and well-being. 
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